Dny Remedies India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth 57.52%
- Ebitda -5.00%
- Net Worth -5.41%
- Total Assets 143.26%
About Dny Remedies India
Dny Remedies India Private Limited (DRIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 April 2016 (Eight years and nine months 26 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Kute and Archana Kute serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100MH2016PTC280385
- Company No.
280385
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2016
- Date of AGM
29 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Dny Remedies India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Kute  | Director | 29-Apr-2016 | Current |
| Archana Kute | Director | 29-Apr-2016 | Current |
Financial Performance of Dny Remedies India.
Dny Remedies India Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 57.52% increase in profit. The company's net worth dipped by a decrease of 5.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dny Remedies India?
In 2020, Dny Remedies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kute Sons Industries Private LimitedSuresh Kute and Archana Kute are mutual person
Kute Sons Dairys LimitedSuresh Kute and Archana Kute are mutual person
Kute Sons Fresh Dairy Private LimitedSuresh Kute and Archana Kute are mutual person
Oao Info India Private LimitedSuresh Kute and Archana Kute are mutual person
Dnr India Autotech Private LimitedSuresh Kute and Archana Kute are mutual person
Tirumalla Edible Oils Refinery India Private LimitedSuresh Kute and Archana Kute are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dny Remedies India?
Unlock and access historical data on people associated with Dny Remedies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dny Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dny Remedies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.